Repression of interferon regulatory factor 3 by the Epstein-Barr virus immediate-early protein Rta is mediated through E2F1 in HeLa cells

Zhu,Liang-Hua; Gao,Shan; Jin,Rui; Zhuang,Li-Li; Jiang,Li; Qiu,Ling-Zhi; Xu,Hua-Guo; Zhou,Guo-Ping

doi:10.3892/mmr.2014.1957

Repression of interferon regulatory factor 3 by the Epstein-Barr virus immediate-early protein Rta is mediated through E2F1 in HeLa cells

Authors:
- Liang-Hua Zhu
- Shan Gao
- Rui Jin
- Li-Li Zhuang
- Li Jiang
- Ling-Zhi Qiu
- Hua-Guo Xu
- Guo-Ping Zhou
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Department of Clinical Laboratory, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: February 17, 2014 https://doi.org/10.3892/mmr.2014.1957
Pages: 1453-1459

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Interferon regulatory factor 3 (IRF-3), an essential transcriptional regulator of the interferon (IFN) genes, is important in the host defense against viral and microbial infection. Epstein-Barr virus (EBV) immediate-early protein replication and transcription activator (Rta) and the transcription factor E2F1 are two important inhibitive factors, which repress IRF-3 expression. Numerous studies have identified that Rta can directly bind to the Rta-response element in promoters of its target genes and regulate their expression. In the present study, we demonstrated that Rta represses the expression of IRF-3 by E2F1 rather than through its traditional way. Transient transfection analysis and chromatin immunoprecipitation (ChIP) assays revealed that the overexpression of Rta elevated the expression of E2F1 and increased the binding of E2F1 to the promoter of IRF-3. The mutation of the E2F1‑binding site and the knocking down of E2F1 by small interfering RNA (siRNA) can eradicate the inhibitory effect of Rta. These results suggested that Rta represses IRF-3 expression by increasing E2F1 binding to the IRF-3 promoter.

View Figures

View References

1	Eason DD, Shepherd AT and Blanck G: Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding. Biochim Biophys Acta. 1446:140–144. 1999. View Article : Google Scholar : PubMed/NCBI
2	Honda K and Taniguchi T: IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 6:644–658. 2006. View Article : Google Scholar : PubMed/NCBI
3	Honda K, Takaoka A and Taniguchi T: Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 25:349–360. 2006.
4	Weaver BK, Kumar KP and Reich NC: Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of doublestranded RNA-activated transcription factor DRAF1. Mol Cell Biol. 18:1359–1368. 1998.PubMed/NCBI
5	Yoneyama M, Suhara W, Fukuhara Y, et al: Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1087–1095. 1998. View Article : Google Scholar : PubMed/NCBI
6	Lin R, Heylbroeck C, Pitha PM and Hiscott J: Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasomemediated degradation. Mol Cell Biol. 18:2986–2996. 1998.
7	Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI
8	Se Thoe SY, Wong KK, Pathmanathan R, Sam CK, Cheng HM and Prasad U: Elevated secretory IgA antibodies to Epstein-Barr virus (EBV) and presence of EBV DNA and EBV receptors in patients with cervical carcinoma. Gynecol Oncol. 50:168–172. 1993.PubMed/NCBI
9	Bentz GL, Liu R, Hahn AM, Shackelford J and Pagano JS: Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology. 402:121–128. 2010. View Article : Google Scholar : PubMed/NCBI
10	Xu HG, Ren W, Lu C and Zhou GP: Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1. Mol Biol Rep. 37:3073–3080. 2010. View Article : Google Scholar : PubMed/NCBI
11	Xu HG, Ren W, Zou L, Wang Y, Jin R and Zhou GP: Direct repression of the human IRF-3 promoter by E2F1. Immunogenetics. 63:189–196. 2011. View Article : Google Scholar : PubMed/NCBI
12	Rogoff HA, Pickering MT, Frame FM, et al: Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol Cell Biol. 24:2968–2977. 2004. View Article : Google Scholar : PubMed/NCBI
13	Melroe GT, DeLuca NA and Knipe DM: Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol. 78:8411–8420. 2004. View Article : Google Scholar : PubMed/NCBI
14	Melroe GT, Silva L, Schaffer PA and Knipe DM: Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology. 360:305–321. 2007. View Article : Google Scholar : PubMed/NCBI
15	Saira K, Zhou Y and Jones C: The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol. 81:3077–3086. 2007. View Article : Google Scholar : PubMed/NCBI
16	Abate DA, Watanabe S and Mocarski ES: Major human cytomegalovirus structural protein pp 65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol. 78:10995–11006. 2004. View Article : Google Scholar : PubMed/NCBI
17	Jaworska J, Gravel A, Fink K, Grandvaux N and Flamand L: Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J Virol. 81:5737–5748. 2007. View Article : Google Scholar : PubMed/NCBI
18	Gruffat H and Sergeant A: Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res. 22:1172–1178. 1994. View Article : Google Scholar : PubMed/NCBI
19	Swenson JJ, Holley-Guthrie E and Kenney SC: Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation. J Virol. 75:6228–6234. 2001. View Article : Google Scholar : PubMed/NCBI
20	Ho CH, Hsu CF, Fong PF, et al: Epstein-Barr virus transcription activator RTA upregulates decoy receptor 3 expression by binding to its promoter. J Virol. 81:4837–4847. 2007. View Article : Google Scholar : PubMed/NCBI
21	Chang LK, Chung JY, Hong YR, et al: Activation of Sp1-mediated transcription by RTA of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 33:6528–6539. 2005. View Article : Google Scholar : PubMed/NCBI
22	Liu C, Sista ND and Pagano JS: Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol. 70:2545–2555. 1996.PubMed/NCBI
23	Swenson JJ, Mauser AE, Kaufmann WK and Kenney SC: The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol. 73:6540–6550. 1999.PubMed/NCBI
24	Guo Q, Sun X, Yuan C, Zhou H, Li Y, Jie G and Jiang G: Effect of Rta protein of Epstein-Barr virus on the cell cycle in HeLa cells. Acta Virol. 55:311–316. 2011. View Article : Google Scholar : PubMed/NCBI